The 20 Best Type 2 Diabetes (T2D) Doctors Near Me in South Lyon, MI

William H. Herman is the Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes, Professor of Internal Medicine in the Division of Metabolism, Endocrinology, and Diabetes and Professor of Epidemiology in the School of Public Health. He completed his undergraduate degree at Yale University and received his medical degree from Boston University. He gained a Masters of Public Health (Epidemiology) from the University of Michigan. Professor Herman's interests include clinical diabetes and diabetes epidemiology, especially in the areas of surveillance, screening, treatment, cost-effective analysis, and health policy. He has authored more than 400 original research papers, reviews and textbook chapters and is U-M Principal Investigator for the Diabetes Control and Complications Trial (DCCT), Epidemiology of Diabetes Interventions and Complications (EDIC), Diabetes Prevention Program (DPP), Diabetes Prevention Program Outcomes Study (DPPOS), and The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Professor Herman received the American Diabetes Association's Kelly West Award for outstanding achievement in diabetes epidemiology in 2006 and the U-M Dean's Award for Clinical and Health Services Research in 2007. From 2018 to 2021, he chaired the National Clinical Care Commission, a federal advisory committee charged with advising the Congress how to leverage federal policies and programs to better prevent and control diabetes in the United States. He has been recognized by Best Doctors as a Best Doctor in America for more than 10 years. Dr. Herman is rated as an Elite provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), Diabetic Neuropathy, and Gastric Bypass. Dr. Herman is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Kara Mizokami-Stout, MD, MSc is an Assistant Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes. She attended medical school and internal medicine residency at the University of Colorado. She then completed her endocrinology fellowship at the University of Michigan. She joined the faculty at the University of Michigan in 2017 and has a dual appointment at the Ann Arbor VA.Dr. Mizokami-Stout’s practice focuses on type 1 diabetes, type 2 diabetes, and general endocrinology. She also conducts health services research in the field of diabetes. Dr. Mizokami is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Diabetic Neuropathy, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Graves Disease. Dr. Mizokami is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Ang is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Jennifer Franzese is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Franzese is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroid Nodule.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Nieves is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Nieves is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Suchitra Zambare is an Endocrinologist practicing medicine in Novi, Michigan. Dr. Zambare is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Hypothyroidism, and Thyroid Storm.

Sima Saberi is an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Saberi is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Nephropathy, Type 1 Diabetes (T1D), Osteoporosis, and Thyroidectomy.

David T. Broome, MD, is a Clinical Assistant Professor of Medicine in the Metabolism, Endocrinology, and Diabetes (MEND) Division of the University of Michigan. Dr. Broome's clinical and research interests are in Type 1 Diabetes Mellitus, Atypical Diabetes and Monogenic Diabetes (including MODY), Type 2 Diabetes Mellitus, Hypoglycemia, Thyroid Cancer and Primary Hyperparathyroidism. Dr. Broome is dedicated to progress in scholarly work, translational research, and was the recipient of the Tait Endowed Research Scholarship for his work in diabetes in medical school, selected to the Clinical Scholars Program in residency, and several research and teaching thereafter, including: the Cleveland Clinic Foundation Endocrinology & Metabolism Institute Research Award, ENDO Experience Travel Award, the Cleveland Clinic Lerner College of Medicine Excellence in Teaching Award, the AACE Domestic Resident Travel Grant, and most recently the Michigan Clinical Trials Academy. Dr. Broome currently serves as a Review Editor on the editorial board for Frontiers in Clinical Diabetes and Healthcare. In his free time, Dr. Broome enjoys ice hockey, cycling, and spending time with family and friends on the beach in Holland, MI. Dr. Broome is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Gestational Diabetes, and Parathyroidectomy. Dr. Broome is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Farah Daneshvar, DO is a Clinical Assistant Professor in the Division of Metabolism, Endocrinology and Diabetes. Dr. Daneshvar received her bachelor's degree from University of Michgian (Ann Arbor, MI) and her medical degree from Michigan State University (Lansing, MI). She completed both her internal medicine residency and chief residency at Sinai Grace Hospital/Detroit Medical Center (Detroit, MI) and then underwent fellowship training in endocrinology at the University of Washington (Seattle, WA).Dr. Daneshvar is involved in medical eduation including medical students, residents, and fellows. She is the preceptor for Fellows’ Clinic for Endocrinology Fellowship Program at the University of Michigan. Dr. Daneshvar is rated as a Distinguished provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 40 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Pituitary Tumor, Prolactinoma, and Exogenous Cushing's syndrome. Dr. Daneshvar is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Kraftson specializes in treating patients with excess weight/obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the Director of the Weight Navigation Program & the Director of the Post Bariatric Endocrinology Clinic. Dr. Kraftson's research, focuses on gaining a better understanding of delivering effective care for individuals with obesity. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the M.E.N.D. Endocrinology Fellowship. Dr. Kraftson is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Obesity, Malnutrition, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy. Dr. Kraftson is board certified in Endocrinology, Diabetes & Metabolism.

Doctor Jennifer Wyckoff is a Clinical Professor of Internal Medicine in the Metabolism, Endocrinology and Diabetes/Podiatry Division. She received her MD degree from the University of South Florida in 1992 and completed her Internal Medicine Residency at the University of Utah in 1995. In addition, Dr. Wyckoff completed a fellowship in Endocrinology at the Brigham and Women's Hospital, Harvard Medical School, in 1999. Following that, she joined the faculty of the Joslin Diabetes Center, Harvard Medical School. While there, she practiced as part of the multidisciplinary Diabetes and Pregnancy program, a joint venture between the Joslin Diabetes Center and the Beth Israel Deaconess Hospital.In 2006, she joined the faculty at University of Michigan. Dr. Wyckoff serves as the Associate Clinical Chief for the Metabolism, Endocrinology and Diabetes/Podiatry Division and the Medical Director of the Adult Diabetes Education. Her clinical interests center on diabetes, with specific emphasis on diabetes and pregnancy, Type 1 diabetes and technology, patient education and cystic fibrosis related diabetes. Dr. Wyckoff is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Secondary Immunodeficiency (SID), and Gestational Diabetes. Dr. Wyckoff is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Yu Kuei Alex Lin is a Clinical Assistant Professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND). After earning his medical degree at Poznan University of Medical Sciences, Poland, he completed his Medicine Residency at Beth Israel Medical Center, NY, and Endocrinology fellowship at Cleveland Clinic, OH. Dr. Lin joined the faculty at Michigan in 2019.Dr. Lin is a clinical diabetes researcher with research focuses on characterizing hypoglycemia (including evaluating impaired awareness of hypoglycemia and unhelpful hypoglycemia beliefs and management behaviors and their associations with hypoglycemia developments) and devising and testing behavioral interventions for improving hypoglycemia self-management. Dr. Lin’s clinical practice focuses on diabetes and general endocrinology. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Pancreatectomy, and Islet Cell Transplantation. Dr. Lin is board certified in Endocrinology, Diabetes & Metabolism.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nevin Ajluni, M.D., joined the team at the Division of Metabolism, Endocrinology & Diabetes (MEND) after serving a two-year endocrinology fellowship in the Division. She is a part of the care team in the MEND Weight Management Program, where she works with obese individuals by applying cutting-edge research findings and novel clinical strategies. She is an honors graduate of the Wayne State University School of Medicine and completed her internship and residency in internal medicine at the McGaw Medical Center of Northwestern University before coming to the University of Michigan. Dr. Ajluni is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), and Congenital Generalized Lipodystrophy. Dr. Ajluni is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Amy E. Rothberg, MD, DABOM is Clinical Professor of Internal Medicine in the Division of Metabolism, Endocrinology and Diabetes (MEND) and Director of the MEND Weight Management Clinic, Research Professor of Nutritional Sciences and Director of Rewind, a virtual weight management and diabetes treatment program. She is an adjunct Professor in the School of Public Health at the University of Michigan.Dr. Rothberg served both her internship and residency in the Department of Internal Medicine at the University of Michigan Medical Center in Ann Arbor. She then completed the fellowship program in the Metabolism, Endocrinology & Diabetes at the University of Michigan Health System in Ann Arbor and then joined the faculty.Dr. Rothberg holds, or is a Co-Investigator, on research grants from the Michigan Nutrition Obesity Research Center, the Michigan Diabetes Research Center, and the National Institutes of Health. Dr. Rothberg is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Obesity, Type 2 Diabetes (T2D), Obesity in Children, Familial Partial Lipodystrophy, and Gastric Bypass. Dr. Rothberg is board certified in Endocrinology, Diabetes & Metabolism.

As director of the Michigan Metabolomics and Obesity Center, Dr. Charles F. Burant facilitates the network of obesity related researchers on the U-M campus which results in enhancing collaborative studies and speeding the translation of basic science findings into clinically useful therapies for metabolic diseases including obesity, Type 2 diabetes and related metabolic disorders.Dr. Burant earned both his medical degree and doctorate of philosophy in molecular and cellular biology from the Medical University of South Carolina in Charleston. His internship and residency were served at the University of California, San Francisco, and he completed his fellowship in the Department of Medicine, Endocrinology Section at the University of Chicago. He joined the University of Michigan faculty in 1999. Dr. Burant is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Obesity, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D). Dr. Burant is board certified in Endocrinology, Diabetes & Metabolism.

Jennifer Iyengar is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Iyengar is rated as an Advanced provider by MediFind in the treatment of Type 2 Diabetes (T2D). She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Thyroid Nodule, Paget's Disease of Bone, and Type 2 Diabetes (T2D).